Document detail
ID

oai:arXiv.org:2407.14058

Topic
Computer Science - Machine Learnin...
Author
Wang, Jingyao Zhao, Siyu Qiang, Wenwen Li, Jiangmeng Sun, Fuchun Xiong, Hui
Category

Computer Science

Year

2024

listing date

1/29/2025

Keywords
learning effective mml causal \ c^3\
Metrics

Abstract

Multi-Modal Learning (MML) aims to learn effective representations across modalities for accurate predictions.

Existing methods typically focus on modality consistency and specificity to learn effective representations.

However, from a causal perspective, they may lead to representations that contain insufficient and unnecessary information.

To address this, we propose that effective MML representations should be causally sufficient and necessary.

Considering practical issues like spurious correlations and modality conflicts, we relax the exogeneity and monotonicity assumptions prevalent in prior works and explore the concepts specific to MML, i.e., Causal Complete Cause (\(C^3\)).

We begin by defining \(C^3\), which quantifies the probability of representations being causally sufficient and necessary.

We then discuss the identifiability of \(C^3\) and introduce an instrumental variable to support identifying \(C^3\) with non-exogeneity and non-monotonicity.

Building on this, we conduct the $C^3$ measurement, i.e., \(C^3\) risk.

We propose a twin network to estimate it through (i) the real-world branch: utilizing the instrumental variable for sufficiency, and (ii) the hypothetical-world branch: applying gradient-based counterfactual modeling for necessity.

Theoretical analyses confirm its reliability.

Based on these results, we propose $C^3$ Regularization, a plug-and-play method that enforces the causal completeness of the learned representations by minimizing \(C^3\) risk.

Extensive experiments demonstrate its effectiveness.

Wang, Jingyao,Zhao, Siyu,Qiang, Wenwen,Li, Jiangmeng,Sun, Fuchun,Xiong, Hui, 2024, On the Causal Sufficiency and Necessity of Multi-Modal Representation Learning

Document

Open

Share

Source

Articles recommended by ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw